Resource Center
Resource Center
To mark World AIDS Day, CHAI talked to patients in Zambia using DRV/r since an affordable generic version became available
Read moreCHAI is pleased to release the 2023 annual HIV market report, providing a detailed look at the complex, ever-changing HIV landscape in low- and middle-income countries based on aggregated market intelligence from our work in over 20 countries.
Read moreThis is the current list of sessions that CHAI is participating in at IAS 2023, taking place virtually and in-person from Brisbane, Australia, from July 23 to 26, 2023. Please note that this page is continuously being updated as participants and sessions are confirmed. Presentation links will be updated when recordings are available, so check...
Read moreHIV remains a significant health issue among children, with almost two million children living with HIV, mostly in low- and middle-income countries. Of these children, less than a million receive the treatment they need to survive. In many low- and middle-income countries, people living with HIV are treated with more affordable generic versions of brand-name...
Read moreCHAI has released the 13th issue of our annual HIV market report detailing the complex, ever-changing HIV commodity markets in low- and middle-income countries based on aggregated market intelligence from our work in over 20 countries.
Read moreA critical second-line HIV treatment called darunavir/ritonavir (DRV/r) is rolling out across Nigeria and Zambia – some of the earliest adopters of many countries that can now access an affordable supply of these medicines following a pricing agreement secured by CHAI and Unitaid last year.
Read moreCHAI announced agreements with leading generic manufacturers to make generic Paxlovid available to low- and middle income countries for under US$25 per treatment course.
Read moreCHAI is supporting the Zimbabwe TB national program to not only roll out new anti-TB treatment, but also to support drug safety monitoring to ensure quality of care for patients.
Read more